Iron supplementation in HIV-infected Malawian children with anemia: a double-blind, randomized, controlled trial.

Background: It is unknown whether iron supplementation in human immunodeficiency virus (HIV)-infected children living in regions with high infection pressure is safe or beneficial. A 2-arm, double-blind, randomized, controlled trial was conducted to examine the effects of iron supplementation on hemoglobin, HIV disease progression, and morbidity.

Methods: HIV-infected Malawian children aged 6-59 months with moderate anemia (hemoglobin level, 7.

Iron deficiency in children with HIV-associated anaemia: a systematic review and meta-analysis.

We conducted a systematic review and meta-analysis to determine the prevalence of iron deficiency in HIV-infected children from high- and low-income settings and compared it with that of HIV-uninfected controls. We searched five major databases for primary studies reporting on anaemia and iron markers in HIV-infected children. A pooled analysis was done using random-effects models, with Forest plots and heterogeneity test estimates provided.